The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease

American Journal of Clinical Pathology

Volumn 127, Issue 2, 2007, Pages 237-247

  Magro, Cynthia M ^a   Marsh, Clay B ^b   Allen, James N ^b   Ross, Patrick ^b   Liff, David ^b   Knight, Deborah A ^b   Waldman, W James ^b   Nadasdy, Tibor ^b   Cowden, Daniel J ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Anti endothelial cell antibody; Collagen vascular disease; Dermatopathology; Microvascular injury; Pulmonary fibrosis

Indexed keywords

CYCLOPHOSPHAMIDE; ENDOTHELIAL CELL ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON; PHOSPHOLIPID ANTIBODY; PREDNISONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; ANTIBODY;

ADULT; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; COLLAGEN DISEASE; COMPLEMENT FACTOR; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROSIS; MALE; MICROSCOPY; MICROVASCULAR INJURY; MICROVASCULATURE; MIXED CONNECTIVE TISSUE DISEASE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SCLERODERMA; SCLERODERMATOMYOSITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; VASCULAR DISEASE; WESTERN BLOTTING; ANIMAL; ENDOTHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; MICROCIRCULATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; COLLAGEN DISEASES; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MICROCIRCULATION; MIDDLE AGED; PULMONARY FIBROSIS; RATS;

EID: 33847010276     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/CNQDMHLH2WGKL32T     Document Type: Article

References (44)

1. Du Bois RM, Wells AU. The lung in rheumatic diseases. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. 3rd ed. Philadelphia, PA: Mosby; 2003:315-324.
2. Nylander Lundqvist E, Back O, Nilsson TK, et al. Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol. 1992;11:248-253.
3. Magro CM, Ross P, Pope-Harman A, et al. Direct and indirect immunofluorescence as a diagnostic adjunct to the interpretation of nonneoplastic lung disease. Am J Clin Pathol. 2003;119:279-289.
4. Wusirika R, Ferri C, Marin M, et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. Am J Clin Pathol. 2003;120:596-606.
5. Hedgpeth MT, Bouware DW. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthritis Rheum. 1988;31:545-548.
6. Mills ES, Mathews MB. Interstitial pneumonitis in dermatomyositis. JAMA. 1956;160:1467-1470.
7. Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990;176:755-759.
8. Schwarz MI, Matthay SA, Sahn RE, et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine. 1976;55:89-104.
9. Magro CM, Waldman WJ, Knight DA, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol. 2006;67:284-297.
10. Fujita J, Dobashi N, Ohtsuki Y, et al. Elevation of anti-cytokeratin 19 antibody in sera of the patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with collagen vascular disorders. Lung. 1999;177:311-319.
11. Ihn H, Sato S, Fujimoto M, et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol. 2000;119:203-209.
12. Mineau-Hanscke R, Patton WF, Hechtman HB, et al. Immunolocalization of cytokeratin 19 in bovine and human microvascular endothelial cells in situ. Comp Biochem Physiol. 1993;104:313-319.
13. Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis. 1981;124:499-503.
14. Tjiu JW, Lin SJ, Wang LF, et al. Digital infarcts showing microangiopathy in adult dermatomyositis suggest severe pulmonary involvement and poor prognosis. Br J Dermatol. 2004;150:1214-1216.
15. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 2002;19:571-576.
16. Lamblin C, Bergoin C, Saelens T, et al. Interstitial lung diseases in collagen vasculat diseases. Eur Respir J Suppl. 2001;32:69S-80S.
17. Jennings CA, King TE Jr, Tuder R, et al. Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med. 1997;155:1101-1109.
18. Schwarz MI, Sutarik JM, Nick JA, et al. Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995;151:2037-2040.
19. Ludatscher RM. Patterns of regeneration in vessels of human diseased muscle and skin: an ultrastructural study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;36:65-75.
20. Braverman IM. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol. 1989;93(2 suppl):2S-9S.
21. Neumark T. Ultrastructural study of neuromuscular and vascular changes in connective-tissue diseases. Int J Tissue React. 1986;8:111-117.
22. Freemont AJ, Hoyland J, Fielding P, et al. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol. 1992;126:561-568.
23. Magro CM, Calomeni EP, Nadasdy T, et al. Ultrastructure as a diagnostic adjunct in the evaluation of lung allograft biopsies. J Ultrastruct Pathol. 2005;29:95-106.
24. Lajoie G. Antibody-mediated rejection of human renal allografts: an electron microscopic study of peritubular capillaries. Ultrastruct Pathol. 1997;21:235-242.
25. Lanto B, Bohm F, Meffert H, et al. The cytotoxic effect of anti-Ro- (SS-A) antibodies and UVA light on human endothelial cells in vitro [in German]. Dermatol Monatsschr. 1990;176:305-311.
26. Magro CM, Crowson AN. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. Am J Dermatopathol. 1999;21:129-137.
27. Mascara JM Jr, Hausmann G, Herrero C, et al. Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol. 1995;131:1386-1392.
28. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27:15-19.
29. Magro CM, Crowson AN, Regauer S. Mixed connective tissue disease: a clinical, histologic, and immunofluorescence study of eight cases. Am J Dermatopathol. 1997;19:206-213.
30. Hesselstrand R, Scheja A, Shen GQ, et al. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford). 2003;42:534-540.
31. Faulk WP, Rose M, Meroni PL, et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol. 1999;60:826-832.
32. Yazici ZA, Behrendt M, Cooper D, et al. The identification of endothelial cell autoantigens. J Autoimmun. 2000;15:41-49.
33. Levine JS, Koh JS, Subang R, et al. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp Mol Pathol. 1999;66:82-98.
34. Pittoni V, Isenberg D. Apoptosis and antiphospholipid antibodies. Semin Arthritis Rheum. 1998;28:163-178.
35. Chan TM, Cheng IK. A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1996;78:41-47.
36. Negi VS, Tripathy NK, Misra R, et al. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol. 1998;25:462-466.
37. Hill MB, Phipps JL, Hughes P, et al. Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes. Br J Haematol. 1998;103:416-421.
38. Lee KH, Bang D, Choi ES, et al. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res. 1999;291:374-381.
39. Tripathy NK, Upadhyaya S, Sinha N, et al. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol. 2001;28:805-808.
40. Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol. 1997;107:120-126.
41. Lucchiari N, Panajotopoulos N, Xu C, et al. Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol. 2000;61:518-527.
42. Lanir N, Zilberman M, Yron I, et al. Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. J Lab Clin Med. 1998;131:548-546.
43. Cines DB, Lyss AP, Reeber LM, et al. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest. 1984;73:611-625.
44. Borg AA, Dawes PT, Mattey DL. Increased levels of IgA antibodies to cytokeratin-18 and epidermal keratin in rheumatoid arthritis. Arthritis Rheum. 1993;36:229-233.